These articles need to be sent to NP and the entire board. Our S/C has some secondary endpoints but primary is mortality. I doubt we get to statistical significance at the 195 patients after reading these articles.

Hopefully we will have EUA already and Leronlimab will be discovered by the medical community.

On the other hand if we do reach statistical significance with mortality it will be a huge achievement.